Business & Finance
Business and Finance
Business and Finance
Fri, June 1, 2012
Thu, May 31, 2012 Essex Angel Capital Inc. Announces Wellness Indicators, Inc.'s Commercial Launch of Health Equater(TM) Assessment Profile
May 31, 2012 17:16 ET
Essex Angel Capital Inc. Announces Wellness Indicators, Inc.'s Commercial Launch of Health Equater™ Assessment Profile
WINDSOR, ONTARIO--(Marketwire - May 31, 2012) - Essex Angel Capital Inc. (TSX VENTURE:EXC) (the "Corporation" or "Essex") is pleased to announce that it has been advised by Wellness Indicators, Inc. ("Wellness Indicators"), one of the companies in its portfolio, of the commercial launch of Wellness Indicators' new product, the Health Equater™ Assessment Profile in July of 2012. The launch date to the U.S. market, previously planned for 4th Quarter of 2012, is being accelerated due to the success of the field trials conducted in the last two months and the positive client feedback.
"The Health Equater™ product has performed well beyond expectations in the field trials," said Frank Lyman, President and CEO of Wellness Indicators. "We kicked off our field trial testing with the National Labor Management Conference ("NLMC") annual meeting in February and tested over 100 union leaders. The NLMC membership includes trusts that represent most of the union employees east of the Mississippi. Clients are waiting for the product when the company releases it, which will result in immediate sales," he added.
"The early commercial launch of the Health Equater™ Assessment Profile is an ideal beginning to a successful introduction of this unique product," said Rick Galdi, Chief Executive Officer of Essex Angel Capital.
Wellness Indicators, based in Wauconda, Illinois, will market the Health Equater™ Assessment Profile to insurance companies, large employers, and organized labor unions, representing millions of potential clients, to use as a precursor to expensive clinical diagnostic tests. The product will be available through FlagshipSailsRX, LLC, a sales company specializing in healthcare and medical products and services. "All of us at Flagship believe that the Health Equater™ test from Wellness Indicators is a true game-changer," said Jeff Zavada, Flagship Partner and co-founder.
The Health Equater™ Assessment Profile is a first-to-market test screening for such biomarkers as oxidative stress, low-grade inflammation and total antioxidant capacity, which indicate levels of wellness. Thousands of studies have shown that the biomarkers detected by the assessment profile are leading indicators for a variety of future health risks, including stroke, cancer, heart disease, and diabetes. The value of the Health Equater™ Assessment Profile is that it is non-invasive, results are ready in five minutes and it gives an indication at the individual level of how a person is functioning metabolically before the onset of chronic disease, when intervention is less expensive and more effective. Results are available in approximately five minutes, instead of the week that traditional lab tests require. Other advantages include ease of use, portability, and low cost, being approximately $30 per test, rather than around $100 for most current diagnostic tests.
About Wellness Indicators, Inc.
Wellness Indicators is part of the investment portfolio of Essex Angel Capital. Wellness Indicators is the developer of a first-to-market new wellness assessment test scheduled for commercial launch in the 3rd Quarter of 2012. The Health Equater™ Assessment Profile is a unique inexpensive urine test that screens for a number of biomarkers indicating levels of wellness; results are available in approximately five minutes. The Health Equater™ system has the potential to fill an enormous unmet need in the wellness industry for a cost-effective easy-to-use portable screening tool.
About Essex Angel Capital
Essex Angel Capital of Windsor, Ontario, is a publicly traded company engaged in the business of debt and equity investment in privately held early-stage companies. Essex is traded on the TSX Venture Exchange under the symbol "EXC."
About FlagshipSailsRX
FlagshipSalesRX is a healthcare sales outsourcing company founded in 2010, which offers to early-stage companies the platform, resources, connections, and tools of Fortune 500 companies. Its specialty is building sales go-to-market strategies and platforms for companies in the healthcare and employee benefits areas. Flagship offers a range of services from building or refining strategy documents to choosing distribution channels to penetrating particular markets with their sales force. Clients are able to leverage a sales team with 20+ years' experience that's already in place and can call on thousands of existing relationships built on trust and proven results. Flagships founders and partners have extensive experience at such companies as United Healthcare, Walgreens, and Aetna, while its Advisory Board features a combination of healthcare entrepreneurs and people with years of experience at large healthcare corporations.
This press release contains certain forward-looking statements about the future plans and intentions of companies in the Corporation's portfolio. Wherever possible, words such as "may," "will," "should," "could," "expect," "plan," "intend," "anticipate," "believe," "estimate," "predict," or "potential," or the negative or other variations of these words, or similar words or phrases, have been used to identify these forward-looking statements. These statements reflect Management's current beliefs and are based on information currently available to Management as at the date hereof. Forward-looking statements included or incorporated by reference in this press release include statements with respect to the commercial launch of Wellness Indicators' new product.
Forward-looking statements involve significant risk, uncertainties, and assumptions. Many factors could cause actual results, performance, or achievements to differ materially from the results discussed or implied in the forward-looking statements. These factors should be considered carefully and readers should not place undue reliance on the forward-looking statements. Although the forward-looking statements contained in this press release are based upon what management believes to be reasonable assumptions, the Corporation cannot assure readers that actual results will be consistent with these forward-looking statements. These forward-looking statements are made as of the date of this press release, and the Corporation assumes no obligation to update or revise them to reflect new events or circumstances, except as required by law.
Neither TSX-V nor its Regulation Services Provider (as that term is defined in the policies of the TSX-V) accepts responsibility for the adequacy or accuracy of this release.
